Attached files
| file | filename |
|---|---|
| 10-Q/A - Sonoma Pharmaceuticals, Inc. | v220053_10qa.htm |
| EX-31.1 - Sonoma Pharmaceuticals, Inc. | v220053_ex31-1.htm |
| EX-31.2 - Sonoma Pharmaceuticals, Inc. | v220053_ex31-2.htm |
| EX-10.44 - Sonoma Pharmaceuticals, Inc. | v220053_ex10-44.htm |
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officers of Oculus Innovative Sciences, Inc., a Delaware corporation (the “Company”), do hereby certify, to such officers’ knowledge, that:
The Amendment to the Quarterly Report on Form 10-Q/A for the quarter ended September 30, 2010 (the “Form 10-Q/A”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q/A fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: April 29, 2011
|
By:
|
/s/ Hojabr Alimi
|
|
|
Hojabr Alimi
|
|||
|
Chief Executive Officer
|
|||
|
Date: April 29, 2011
|
By:
|
/s/ Robert Miller
|
|
|
Robert Miller
|
|||
|
Chief Financial Officer
|
|||